Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MannKind
MannKind
Think Like a Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives on Six Exciting Biotechs
IT Business Net
Sat, 05/17/14 - 10:38 am
Opexa
Biocryst
Rexahn
Corcept Therapeutics
Ligand Pharmaceuticals
MannKind
Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs
Seeking Alpha
Fri, 05/16/14 - 08:20 am
Amgen
Biocryst
GSK
Corcept Therapeutics
Merck KGaA
Ligand Pharmaceuticals
MannKind
Pfizer
Shire
Receptos
Opexa
What's Hurting Biotechnology Stocks?
Seeking Alpha
Tue, 05/13/14 - 11:37 am
biotech
Gilead Sciences
InterMune
MannKind
Amgen
Celgene
Biogen Idec
MannKind: Forget Earnings, All Eyes On July
Seeking Alpha
Tue, 05/13/14 - 11:21 am
MannKind
Afrezza
diabetes
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wed, 04/23/14 - 11:57 am
Juxtapid
Otezla
Aegerion
Celgene
GW Pharma
Sativex
Intercept Pharma
OCA
Ironwood Pharmaceuticals
Linzess
Lpath
iSONEP
MannKind
Afrezza
Xtandi
H.P. Acthar Gel
Questcor Pharmaceuticals
eteplirsen
Sarepta Therapeutics
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data
Yahoo/Zacks.com
Wed, 04/16/14 - 10:22 am
MannKind
Alkermes
Gilead Sciences
ledipasvir
AbbVie
Afrezza
aripiprazole lauroxil
Pharmacyclics
Imbruvica
This Week in Biotech: The Questcor Buyout and MannKind's Giant Leap to Nowhere
Motley Fool
Sun, 04/13/14 - 10:14 am
Questcor
MannKind
Agios Pharmaceuticals
Mallinckrodt
Alkermes
Merck
The Stalled State Of MannKind
Seeking Alpha
Fri, 04/11/14 - 11:38 am
MannKind
diabetes
Afrezza
Oramed Can Benefit As MannKind Opens The Diabetes Market For Novel Drugs
Seeking Alpha
Tue, 04/8/14 - 11:48 am
Oramed
MannKind
diabetes
ORMD-0801
FDA Keeps Driving Up Future Cost of Inhalable Insulin
Yahoo/247WallStreet
Mon, 04/7/14 - 12:56 pm
FDA
inhaled insulin
diabetes
Afrezza
MannKind
MannKind Announces FDA Extends PDUFA Date for AFREZZA By 3 Months
Yahoo/Benzinga
Mon, 04/7/14 - 08:44 am
FDA
Afrezza
diabetes
MannKind
Will The Third Time Be A Charm For MannKind? Leading Fund Managers Definitely Think So
Seeking Alpha
Sun, 04/6/14 - 10:23 am
MannKind
Afrezza
inhaled insulin
diabetes
How MannKind Shows Depth Of The Diabetes Market
Seeking Alpha
Thu, 04/3/14 - 08:59 am
MannKind
diabetes
Afrezza
Can MannKind Shares Double Again on FDA Approval?
24/7 Wall St
Wed, 04/2/14 - 07:46 am
FDA
Afrezza
diabetes
MannKind
MannKind Wins U.S. Panel Backing for Its Inhaled Insulin
Bloomberg
Tue, 04/1/14 - 10:20 pm
MannKind
inhaled insulin
Afrezza
FDA
diabetes
advisory panels
Mannkind Afrezza FDA Panel Live Blog
TheStreet.com
Tue, 04/1/14 - 08:07 am
FDA
Afrezza
MannKind
advisory panels
insulin
Shares of MannKind Plummet Prior to Drug Advisory Meeting
Yahoo/Benzinga
Mon, 03/31/14 - 04:23 pm
FDA
MannKind
Afrezza
Mannkind: The Best Afrezza FDA Panel Preview Ever
TheStreet.com
Mon, 03/31/14 - 09:53 am
FDA
Afrezza
advisory panels
diabetes
MannKind
FDA staff review raises questions about MannKind diabetes device
Yahoo/Reuters
Sat, 03/29/14 - 09:13 am
MannKind
diabetes
type 2 diabetes
Mannkind Shares Dip After FDA Group Raises Afrezza Concerns
FOX Business
Fri, 03/28/14 - 01:00 pm
MannKind
FDA
Afrezza
insulin
diabetes
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »